# Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases

> **NCT00899574** · PHASE2 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 10 (actual)

## Conditions studied

- Breast Cancer
- Breast Neoplasms

## Interventions

- **DRUG:** Imiquimod

## Key facts

- **NCT ID:** NCT00899574
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2011-04
- **Final completion:** 2013-06
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2015-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00899574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00899574, "Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00899574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*